VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
XERS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
XERSXeris Biopharma Holdings, Inc.
$8.94$1.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksXERSQuarterly Financials

Xeris Biopharma Holdings, Inc. (XERS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Xeris Biopharma Holdings, Inc. (XERS) quarterly income statement — complete revenue, gross profit & net income history

XERS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue83.13M85.81M74.38M71.54M60.12M60.1M54.27M48.06M40.64M44.39M48.32M38.01M33.2M33.14M29.73M25.31M22.07M21.67M11.04M8.91M
Revenue Growth %38.27%42.78%37.06%48.84%47.94%35.39%12.31%26.46%22.42%33.93%62.56%50.19%50.39%52.96%169.37%184.15%169.35%202.13%16.8%339.37%
Cost of Goods Sold13.28M19.08M11M14.61M8.73M9.48M13.59M10.5M5.97M10.28M8.2M7.55M5.32M6.29M5.26M4.81M6.27M4.89M3.22M3.38M
COGS % of Revenue15.98%22.23%14.78%20.42%14.52%15.77%25.05%21.85%14.69%23.16%16.97%19.88%16.02%18.98%17.7%19.01%28.42%22.56%29.18%37.99%
Gross Profit69.84M66.73M63.38M56.93M51.39M50.62M40.67M37.56M34.67M34.11M40.12M30.45M27.88M26.85M24.46M20.5M15.8M16.78M7.82M5.52M
Gross Margin %84.02%77.77%85.22%79.58%85.48%84.23%74.95%78.15%85.31%76.84%83.03%80.12%83.98%81.02%82.3%80.99%71.58%77.44%70.82%62.01%
Gross Profit Growth %35.91%31.82%55.83%51.55%48.24%48.41%1.39%23.35%24.36%27.02%63.99%48.58%76.44%60.03%213.05%271.1%148.08%345.68%18.12%658.65%
Operating Expenses61.93M49.95M56.65M52.45M54.48M48.94M53.57M45.75M48.91M43.95M45.03M46.43M41.15M42.02M43.24M39.41M44.87M65.05M32.17M31.31M
OpEx % of Revenue74.5%58.22%76.17%73.31%90.62%81.44%98.71%95.19%120.36%99.01%93.2%122.16%123.97%126.79%145.48%155.74%203.3%300.2%291.55%351.56%
Selling, General & Admin53.14M47.5M46.46M44.39M44.02M40.14M44.97M39.99M38.38M37.57M37.29M37.63M33.6M34.36M34.49M32.98M35.91M54.18M26.54M25.93M
SG&A % of Revenue63.93%55.36%62.46%62.05%73.22%66.79%82.86%83.21%94.44%84.63%77.17%99.02%101.23%103.66%116.03%130.34%162.7%250.03%240.46%291.12%
Research & Development8.78M7.87M7.48M8.05M7.75M6.09M5.89M5.76M7.82M6.38M5.03M6.09M4.84M4.96M6.04M3.72M6.25M10.08M5.66M5.38M
R&D % of Revenue10.57%9.18%10.06%11.26%12.9%10.14%10.85%11.98%19.25%14.38%10.42%16.01%14.57%14.95%20.33%14.69%28.32%46.53%51.32%60.44%
Other Operating Expenses0-1000K1000K01000K1000K1000K01000K01000K1000K1000K1000K1000K1000K1000K790K-25K0
Operating Income7.92M16.77M6.73M4.48M-3.09M1.68M-12.89M-8.19M-14.24M-9.84M-4.91M-15.98M-13.28M-15.17M-18.78M-18.92M-29.07M-48.27M-24.36M-25.79M
Operating Margin %9.52%19.55%9.05%6.27%-5.14%2.79%-23.76%-17.03%-35.05%-22.17%-10.17%-42.04%-40%-45.77%-63.18%-74.75%-131.72%-222.77%-220.73%-289.55%
Operating Income Growth %356.18%898.99%152.21%154.75%78.31%117.06%-162.43%48.76%-7.29%35.13%73.84%15.53%54.33%68.57%22.9%26.65%-73.68%-149.55%-77.23%-16.13%
EBITDA11.13M19.82M9.92M7.65M53K4.81M-9.77M-5.03M-11.03M-6.58M-1.56M-12.62M-10.1M-11.67M-15.71M-15.85M-26.04M-47.37M-24.04M-25.47M
EBITDA Margin %13.38%23.1%13.34%10.69%0.09%8.01%-18%-10.47%-27.14%-14.83%-3.22%-33.19%-30.41%-35.2%-52.85%-62.65%-117.98%-218.62%-217.81%-285.95%
EBITDA Growth %20892.45%311.87%201.55%251.92%100.48%173.11%-527.83%60.11%-9.26%43.58%90.09%20.42%61.23%75.37%34.64%37.75%-58.76%-150.69%-79.89%-16.36%
D&A (Non-Cash Add-back)3.21M3.05M3.19M3.16M3.14M3.13M3.12M3.15M3.21M3.26M3.36M3.36M3.18M3.5M3.07M3.06M3.03M899K323K320K
EBIT7.92M11.08M7.89M5.43M-1.92M2.59M-11.28M-6.29M-11.64M-6.61M-5.68M-13.99M-10.62M-8.9M-18.18M-23.08M-30.6M-48.99M-24.21M-25.72M
Net Interest Income-5.68M-5.69M-6.11M-6.41M-6.13M-6.79M-6.59M-6.67M-5.11M-5.91M-5.73M-5.3M-4.92M-2.52M-3.52M-3.25M-3.45M-1.73M-1.73M-1.72M
Interest Income1.2M1.46M1.16M948K1.18M910K1.2M1.29M1.92M1.11M1.12M1.22M1.3M1.84M472K195K68K70K66K77K
Interest Expense6.88M7.15M7.27M7.36M7.3M7.7M7.79M7.96M7.03M7.02M6.85M6.53M6.22M4.37M3.99M3.45M3.52M1.8M1.8M1.79M
Other Income/Expense-5.68M-5.69M-6.11M-6.41M-6.13M-6.79M-6.17M-6.07M-4.43M-3.79M-7.61M-4.54M-3.56M1.9M-3.39M-7.61M-5.05M-2.52M-1.65M-1.73M
Pretax Income2.23M11.08M621K-1.93M-9.22M-5.11M-19.06M-14.26M-18.67M-13.63M-12.53M-20.52M-16.83M-13.27M-22.17M-26.52M-34.12M-50.79M-26.01M-27.52M
Pretax Margin %2.69%12.91%0.83%-2.7%-15.34%-8.51%-35.13%-29.66%-45.95%-30.7%-25.93%-53.98%-50.71%-40.03%-74.58%-104.81%-154.59%-234.39%-235.7%-308.95%
Income Tax000000-3.32M749K307K-236K-338K-675K0-338K-339K-339K-408K000
Effective Tax Rate %0%0%0%0%0%0%17.44%-5.25%-1.64%1.73%2.7%3.29%0%2.55%1.53%1.28%1.2%0%0%0%
Net Income2.23M11.08M621K-1.93M-9.22M-5.11M-15.74M-15.01M-18.98M-13.39M-12.19M-19.84M-16.83M-12.93M-21.83M-26.18M-33.71M-50.79M-26.01M-27.52M
Net Margin %2.69%12.91%0.83%-2.7%-15.34%-8.51%-29%-31.22%-46.71%-30.16%-25.23%-52.2%-50.71%-39.01%-73.44%-103.47%-152.74%-234.39%-235.7%-308.95%
Net Income Growth %124.23%316.72%103.95%87.15%51.42%61.81%-29.12%24.38%-12.75%-3.56%44.17%24.22%50.07%74.54%16.06%4.83%-83.12%-132.37%-62.56%-14.17%
Net Income (Continuing)2.23M11.08M621K-1.93M-9.22M-5.11M-15.74M-15.01M-18.98M-13.39M-12.19M-19.84M-16.83M-12.93M-21.83M-26.18M-33.71M-50.79M-26.01M-27.52M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.010.060.00-0.01-0.06-0.03-0.11-0.10-0.14-0.10-0.09-0.14-0.12-0.10-0.16-0.19-0.25-0.42-0.39-0.41
EPS Growth %120.83%279.3%102.73%87.9%56.79%64.6%-24.58%28.57%-16.67%-1.89%44.81%26.32%52%77.36%58.97%53.66%16.67%-2.44%-11.43%34.92%
EPS (Basic)0.010.070.00-0.01-0.06-0.03-0.11-0.10-0.14-0.10-0.09-0.14-0.12-0.10-0.16-0.19-0.25-0.42-0.39-0.41
Diluted Shares Outstanding177.63M180.07M177.62M155.97M152.45M149.09M148.99M148.35M140.51M138.12M138.06M137.34M137.14M135.99M135.95M135.53M135.03M121.94M66.5M66.37M
Basic Shares Outstanding170.52M165.96M177.62M155.97M152.45M149.09M148.99M148.35M140.51M138.12M138.06M137.34M137.14M135.99M135.95M135.53M135.03M121.72M66.5M66.37M
Dividend Payout Ratio--------------------